Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation.

Steroids - 1 Nov 2009

Sten Taina, Finel Moshe, Ask Birgitta, Rane Anders, Ekström Lena

Abstract excerpt

Testosterone and epitestosterone are secreted mainly as glucuronide metabolites and the urinary ratio of testosterone glucuronide to epitestosterone glucuronide, often called T/E, serves as a marker for possible anabolic steroids abuse by athletes. UDP-glucuronosyltransferase (UGT) 2B17 is the most important catalyst of testosterone glucuronidation. The T/E might be affected by drugs that interact with UGT2B17,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Glucuronides
Share to Glucuronosyltransferase

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Microsomes

Share to Minor Histocompatibility Antigens

Share to Recombinant Proteins

Share to Testosterone

Source

Identifiers

PMID: 19643121
DOI: 10.1016/j.steroids.2009.07.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation.PMID 19643121Read ↗

Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.Semantic proximity Read ↗

UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse.Semantic proximity Read ↗

Androgen sulfation in healthy UDP-glucuronosyl transferase 2B17 enzyme-deficient men.Semantic proximity Read ↗

[Testosterone metabolism and doping test results].Semantic proximity Read ↗

Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.Semantic proximity Read ↗

Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.Semantic proximity Read ↗

Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability.Semantic proximity Read ↗

Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroidsSemantic proximity Read ↗

Effectiveness of blood steroidal passport markers for detecting testosterone abuse in Asians.Semantic proximity Read ↗

Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.Semantic proximity Read ↗

Normalized Testosterone Glucuronide as a Potential Urinary Biomarker for Highly Variable UGT2B17 in Children 7-18 Years.Semantic proximity Read ↗

Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.